All lobbying filings

DLA PIPER LLP (US)

DLA PIPER LLP (US) filed a Q3 termination report for RESMED CORP. on October 16, 2025, reporting $40,000 in lobbying income.

Lobbying for RESMED CORP. · Medical device manufacturer and digital health company.

All filings by DLA PIPER LLP (US) · Everything RESMED CORP. has reported

Filing · LD-2 quarterly report Q3 termination

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 16, 2025

Income

$40,000

What the client paid this registrant for the period.

Client based in

California

Representation ended

Aug 31, 2025

The registrant reported terminating its work for this client.

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Issues related to medical devices and healthcare policy. Supply chain issues.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.